RedHill Biopharma (RDHL) Inventory (2022 - 2024)

RedHill Biopharma (RDHL) has disclosed Inventory for 3 consecutive years, with $3.7 million as the latest value for Q4 2024.

  • Quarterly Inventory fell 16.81% to $3.7 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2024, down 16.81% year-over-year, with the annual reading at $3.7 million for FY2024, 16.81% down from the prior year.
  • Inventory for Q4 2024 was $3.7 million at RedHill Biopharma, down from $4.4 million in the prior quarter.
  • The five-year high for Inventory was $9.7 million in Q4 2022, with the low at $3.7 million in Q4 2024.
  • Average Inventory over 3 years is $5.9 million, with a median of $4.4 million recorded in 2023.
  • The sharpest move saw Inventory crashed 54.75% in 2023, then decreased 16.81% in 2024.
  • Over 3 years, Inventory stood at $9.7 million in 2022, then plummeted by 54.75% to $4.4 million in 2023, then fell by 16.81% to $3.7 million in 2024.
  • According to Business Quant data, Inventory over the past three periods came in at $3.7 million, $4.4 million, and $9.7 million for Q4 2024, Q4 2023, and Q4 2022 respectively.